| Pharmaceutical Information |
| Drug Name |
Ioxaglate meglumine |
| Drug ID |
BADD_D01187 |
| Description |
Ioxaglic acid is marketed as Hexabrix. This drug is an ionic tri-iodinated benzoate used as a low-osmolality contrast agent during diagnostic imaging procedures. Like other organic iodine compounds, ioxaglic acid blocks x-rays and is opaque in its appearance on x-ray film, improving the visualization of important structures and organs during angiography, arteriography, arthrography, cholangiography, urography, and computed tomography [L1889].
Ioxaglic acid has a low osmolarity and is associated with fewer side effects compared to older contrast agents [L1883]. |
| Indications and Usage |
This medicinal product is for diagnostic use only in adults and children as a low-osmolality medium [L1883], [A7924]. |
| Marketing Status |
Discontinued |
| ATC Code |
V08AB03 |
| DrugBank ID |
DB09313
|
| KEGG ID |
D04598
|
| MeSH ID |
D007485
|
| PubChem ID |
20055342
|
| TTD Drug ID |
D0X7IT
|
| NDC Product Code |
Not Available |
| Synonyms |
Ioxaglic Acid | Ioxaglate Meglumine | Meglumine, Ioxaglate | Methylglucamine Ioxaglate | Ioxaglate, Methylglucamine | Hexabrix | Ioxaglic Acid, Calcium Salt (2:1) | P-286 (Contrast Media) | P286 (Contrast Media) | Ioxaglate | Ioxaglate Sodium | Ioxaglic Acid Monosodium Salt |
|
| Chemical Information |
| Molecular Formula |
C31H38I6N6O13 |
| CAS Registry Number |
59018-13-2 |
| SMILES |
CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)
C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
